Showing results (1-10 of 4,483) with videos related to
Sort By:
Pageof 449
Frontiers in Medicine|February 17, 2025
The diagnosis of DIC: a current overviewHongyu Yang, Xiaochun Ma, Xu LiTrials|July 30, 2025
Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trialHongyu Yang, Jianshuang Feng, Yuteng Ma, et al.British Journal of Haematology|August 24, 2017
The role of heparin in sepsis: much more than just an anticoagulantXu Li, Xiaochun MaCritical Care (London, England)|May 8, 2020
Acute respiratory failure in COVID-19: is it "typical" ARDS?Xu Li, Xiaochun MaInternational Journal of Hematology|April 5, 2022
Phenotype-oriented anticoagulant therapy for sepsis: still a work in progressSihan Yu, Xiaochun Ma, Xu LiZhonghua Wei Zhong Bing Ji Jiu Yi Xue|January 4, 2020
[Effect of heparin on histone-mediated the expression of von Willebrand factor and fibrinogen in lung tissue]Lu Li, Xiaochun Ma, Xu LiZhonghua Wei Zhong Bing Ji Jiu Yi Xue|November 28, 2019
[Heparin inhibits lipopolysaccharide-induced adhesion of monocytes to endothelial cells]Tianlu Chen, Xiaochun Ma, Xu LiZhonghua Wei Zhong Bing Ji Jiu Yi Xue|February 11, 2015
[Unfractionated heparin inhibits lipopolysaccharide-induced expression of granulocyte colony-stimulating factor in human endothelial cells through Toll-like receptor 4 signaling pathway]Xu Li, Yina Liu, Xiaochun MaCytokine|July 6, 2012
Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cellXu Li, Zhen Zheng, Xin Li, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 18, 2018
Unfractionated Heparin Modulates Lipopolysaccharide-Induced Cytokine Production by Different Signaling Pathways in THP-1 CellsXu Li, Enfang Zhao, Lu Li, et al.Pageof 449